🇺🇸 FDA
Patent

US 12084489

Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection

granted A61KA61K47/6803A61K47/6839

Quick answer

US patent 12084489 (Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K47/6803, A61K47/6839, A61P, A61P31/22